Digistain Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Digistain General Information

Description

Developer of tumor profiling technology designed to predict the risk of recurrence in breast cancer patients. The company's technology utilizes advanced AI and spectral signature analysis of key biomarkers from biopsy samples, generating comprehensive data points, enabling healthcare providers to expand access to crucial cancer recurrence prediction tests for a broader market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 101, Interchange Business Park
  • Howard Way
  • Newport Pagnell MK16 9PY
  • England, United Kingdom
+44 020
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Corporate Office
  • Unit 101, Interchange Business Park
  • Howard Way
  • Newport Pagnell MK16 9PY
  • England, United Kingdom
+44 020

Digistain Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Digistain Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 04-Jun-2026 Completed Generating Revenue
8. Later Stage VC 30-Jun-2025 Completed Generating Revenue
7. Later Stage VC 01-Jan-2024 Completed Generating Revenue
6. Accelerator/Incubator 24-Mar-2023 Completed Generating Revenue
5. Grant 01-Jan-2023 Completed Generating Revenue
4. Seed Round 09-Aug-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Angel (individual) $346K $346K Completed Startup
1. University Spin-Out 22-Nov-2019 Completed Startup
To view Digistain’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Digistain Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tumor profiling technology designed to predict the risk of recurrence in breast cancer patients. The compan
Decision/Risk Analysis
Newport Pagnell, United Kingdom
19 As of 2026

Johns Creek, GA
 

Windsor Mill, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Digistain Competitors (5)

One of Digistain’s 5 competitors is JvionAI, a Formerly PE-Backed company based in Johns Creek, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
JvionAI Formerly PE-Backed Johns Creek, GA
iQuartic Formerly VC-backed Windsor Mill, MD
NantHealth Formerly VC-backed Lewisville, TX
Amiko Venture Capital-Backed Milan, Italy
REPROSENT Venture Capital-Backed Los Gatos, CA
You’re viewing 5 of 5 competitors. Get the full list »

Digistain Patents

Digistain Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024156982-A1 Prognosticating risk of a clinical outcome Inactive 24-Jan-2023

Digistain Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Digistain Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hub71 Accelerator/Incubator
007 Venture Partners Venture Capital Minority
Gaingels Venture Capital Minority
Oxford Technology Management Venture Capital Minority
The NHS Innovation Accelerator Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

Digistain FAQs

  • When was Digistain founded?

    Digistain was founded in 2019.

  • Where is Digistain headquartered?

    Digistain is headquartered in Newport Pagnell, United Kingdom.

  • What is the size of Digistain?

    Digistain has 19 total employees.

  • What industry is Digistain in?

    Digistain’s primary industry is Decision/Risk Analysis.

  • Is Digistain a private or public company?

    Digistain is a Private company.

  • What is Digistain’s current revenue?

    The current revenue for Digistain is .

  • How much funding has Digistain raised over time?

    Digistain has raised $2.47M.

  • Who are Digistain’s investors?

    Hub71, 007 Venture Partners, Gaingels, Oxford Technology Management, and The NHS Innovation Accelerator are 5 of 10 investors who have invested in Digistain.

  • Who are Digistain’s competitors?

    JvionAI, iQuartic, NantHealth, Amiko, and REPROSENT are competitors of Digistain.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process